---
title: "HWPC's subsidiary raw material drug salbutamol hydrochloride has received the approval notice for its listing application"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246955863.md"
description: "HWPC's wholly-owned subsidiary Hunan HWPC Pharmaceutical Co., Ltd. recently received approval from the National Medical Products Administration for the marketing application notification of Levosalbutamol Hydrochloride. This drug is the active pharmaceutical ingredient for Levosalbutamol Hydrochloride nebulized inhalation solution, primarily used for the treatment or prevention of bronchospasm caused by reversible airway obstructive diseases in adults and children over 6 years old"
datetime: "2025-07-02T09:42:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246955863.md)
  - [en](https://longbridge.com/en/news/246955863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246955863.md)
generator: "portal-rs"
---

# HWPC's subsidiary raw material drug salbutamol hydrochloride has received the approval notice for its listing application

According to the announcement from Warner Pharmaceuticals (688799.SH), its wholly-owned subsidiary Hunan Warner Pharmaceutical Co., Ltd. (referred to as "Chiral Drugs") has recently received the "Approval Notice for the Market Application of Chemical Raw Materials for Levosalbutamol Hydrochloride" (Notice No.: 2025YS00520) issued by the National Medical Products Administration. This information has been published on the "Raw and Auxiliary Material Registration Information" platform of the Center for Drug Evaluation (CDE) of the National Medical Products Administration.

Levosalbutamol hydrochloride is the active pharmaceutical ingredient for the nebulized inhalation solution of salbutamol hydrochloride. The nebulized inhalation solution of salbutamol hydrochloride is used for the treatment or prevention of bronchospasm caused by reversible airway obstructive diseases in adults and children over 6 years old

### Related Stocks

- [688799.CN](https://longbridge.com/en/quote/688799.CN.md)

## Related News & Research

- [ETF Savings Plans Boom in Switzerland – But Not Because of AI](https://longbridge.com/en/news/296473012.md)
- [YMTC's STAR Mkt IPO Application Accepted, w/ Plans to Raise RMB33B](https://longbridge.com/en/news/296724109.md)
- [Dino Polska S.A. (WSE:DNP) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296763667.md)
- [Tactical Resources, A U.S.-Focused Rare Earth Elements Development Company, Begins Trading On Nasdaq Under Ticker Symbol “TREO” | TREO Stock News](https://longbridge.com/en/news/296509791.md)
- [16:47 ETMr. Muscle Car Engels Gualdani Educates on Private Sales Transactions Between Collectors Via Expert Website from HelloNation](https://longbridge.com/en/news/296534869.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**